Autoimmune & ArthritisWhy Harmful Antibodies Can Persist After Autoimmune Treatment
Why do harmful antibodies sometimes persist after autoimmune treatment? This review examines long-lived plasma cells, immune cells that can keep making antibodies even when other immune cells are depleted. They normally preserve protection against infections, but some may sustain autoimmune disease. The authors focus on rheumatic diseases and selected conditions driven by antibodies, with special attention to lupus and kidney inflammation caused by lupus. Treatments aimed at plasma cells have shown encouraging clinical signals, but most evidence comes from early trials, uncontrolled studies, or specific diseases. The main takeaway is that doctors need stronger evidence identifying when these cells actually sustain disease before targeting them. No single marker reliably identifies a long-lived plasma cell. This summary is based only on the abstract, which does not provide detailed treatment benefits or safety results.
